nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HTR1A—stomach cancer	0.403	1	CbGaD
Iloperidone—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.033	0.161	CbGbCtD
Iloperidone—CYP3A7—Irinotecan—stomach cancer	0.033	0.161	CbGbCtD
Iloperidone—CYP3A5—Irinotecan—stomach cancer	0.0247	0.121	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0241	0.118	CbGbCtD
Iloperidone—CYP3A7—Docetaxel—stomach cancer	0.0241	0.118	CbGbCtD
Iloperidone—CYP3A5—Docetaxel—stomach cancer	0.0181	0.0884	CbGbCtD
Iloperidone—CYP1A2—Fluorouracil—stomach cancer	0.0177	0.0861	CbGbCtD
Iloperidone—CYP3A4—Irinotecan—stomach cancer	0.00964	0.047	CbGbCtD
Iloperidone—HTR7—myenteric nerve plexus—stomach cancer	0.0092	0.118	CbGeAlD
Iloperidone—CYP2D6—Doxorubicin—stomach cancer	0.00828	0.0404	CbGbCtD
Iloperidone—CYP3A4—Docetaxel—stomach cancer	0.00706	0.0345	CbGbCtD
Iloperidone—HTR7—vagus nerve—stomach cancer	0.00613	0.0786	CbGeAlD
Iloperidone—HTR7—vein—stomach cancer	0.00593	0.076	CbGeAlD
Iloperidone—HTR2A—myenteric nerve plexus—stomach cancer	0.00573	0.0735	CbGeAlD
Iloperidone—CYP3A4—Doxorubicin—stomach cancer	0.00527	0.0257	CbGbCtD
Iloperidone—HTR2A—vagus nerve—stomach cancer	0.00382	0.049	CbGeAlD
Iloperidone—HTR2A—vein—stomach cancer	0.0037	0.0474	CbGeAlD
Iloperidone—HTR1D—blood vessel—stomach cancer	0.00236	0.0303	CbGeAlD
Iloperidone—Gefitinib—CHEK2—stomach cancer	0.00217	0.333	CrCbGaD
Iloperidone—HTR7—blood vessel—stomach cancer	0.00188	0.0241	CbGeAlD
Iloperidone—CYP3A7—endocrine gland—stomach cancer	0.00126	0.0161	CbGeAlD
Iloperidone—Paliperidone—HTR1A—stomach cancer	0.00122	0.188	CrCbGaD
Iloperidone—HTR2A—blood vessel—stomach cancer	0.00117	0.015	CbGeAlD
Iloperidone—CYP3A7—liver—stomach cancer	0.00113	0.0145	CbGeAlD
Iloperidone—Cisapride—CYP2A6—stomach cancer	0.00106	0.164	CrCbGaD
Iloperidone—HTR1A—hematopoietic system—stomach cancer	0.00105	0.0134	CbGeAlD
Iloperidone—SIGMAR1—smooth muscle tissue—stomach cancer	0.00103	0.0132	CbGeAlD
Iloperidone—HTR7—hematopoietic system—stomach cancer	0.001	0.0128	CbGeAlD
Iloperidone—ADRA1A—hematopoietic system—stomach cancer	0.000966	0.0124	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—liver—stomach cancer	0.000964	0.0124	CbGeAlD
Iloperidone—SIGMAR1—pancreas—stomach cancer	0.000954	0.0122	CbGeAlD
Iloperidone—HTR7—epithelium—stomach cancer	0.000915	0.0117	CbGeAlD
Iloperidone—Risperidone—HTR1A—stomach cancer	0.00091	0.14	CrCbGaD
Iloperidone—ADRA1A—epithelium—stomach cancer	0.000883	0.0113	CbGeAlD
Iloperidone—HTR7—smooth muscle tissue—stomach cancer	0.000882	0.0113	CbGeAlD
Iloperidone—Gefitinib—EGFR—stomach cancer	0.000866	0.133	CrCbGaD
Iloperidone—CYP1A2—hematopoietic system—stomach cancer	0.000799	0.0102	CbGeAlD
Iloperidone—CYP3A5—hematopoietic system—stomach cancer	0.00077	0.00987	CbGeAlD
Iloperidone—SIGMAR1—bone marrow—stomach cancer	0.000751	0.00963	CbGeAlD
Iloperidone—ADRA2C—pancreas—stomach cancer	0.000749	0.00961	CbGeAlD
Iloperidone—HRH1—hematopoietic system—stomach cancer	0.000748	0.00958	CbGeAlD
Iloperidone—ADRA2A—hematopoietic system—stomach cancer	0.000734	0.00941	CbGeAlD
Iloperidone—CYP2E1—hematopoietic system—stomach cancer	0.000718	0.00921	CbGeAlD
Iloperidone—HTR7—digestive system—stomach cancer	0.000696	0.00893	CbGeAlD
Iloperidone—HRH1—epithelium—stomach cancer	0.000683	0.00876	CbGeAlD
Iloperidone—ADRA1A—lymphoid tissue—stomach cancer	0.00068	0.00872	CbGeAlD
Iloperidone—HRH1—smooth muscle tissue—stomach cancer	0.000659	0.00844	CbGeAlD
Iloperidone—CYP3A5—pancreas—stomach cancer	0.000627	0.00804	CbGeAlD
Iloperidone—HTR2A—hematopoietic system—stomach cancer	0.000624	0.008	CbGeAlD
Iloperidone—SIGMAR1—liver—stomach cancer	0.000607	0.00778	CbGeAlD
Iloperidone—HTR1A—endocrine gland—stomach cancer	0.000602	0.00772	CbGeAlD
Iloperidone—ADRA2A—pancreas—stomach cancer	0.000598	0.00767	CbGeAlD
Iloperidone—CYP3A4—hematopoietic system—stomach cancer	0.000578	0.00741	CbGeAlD
Iloperidone—HTR7—endocrine gland—stomach cancer	0.000575	0.00738	CbGeAlD
Iloperidone—HTR2A—epithelium—stomach cancer	0.000571	0.00732	CbGeAlD
Iloperidone—CYP2D6—hematopoietic system—stomach cancer	0.000569	0.00729	CbGeAlD
Iloperidone—CYP1A2—digestive system—stomach cancer	0.000555	0.00712	CbGeAlD
Iloperidone—ADRA1A—endocrine gland—stomach cancer	0.000555	0.00711	CbGeAlD
Iloperidone—HTR2A—smooth muscle tissue—stomach cancer	0.00055	0.00705	CbGeAlD
Iloperidone—DRD2—endocrine gland—stomach cancer	0.000544	0.00697	CbGeAlD
Iloperidone—CYP3A5—digestive system—stomach cancer	0.000536	0.00687	CbGeAlD
Iloperidone—HRH1—digestive system—stomach cancer	0.00052	0.00667	CbGeAlD
Iloperidone—HTR7—liver—stomach cancer	0.000519	0.00665	CbGeAlD
Iloperidone—CYP2E1—lymphoid tissue—stomach cancer	0.000506	0.00648	CbGeAlD
Iloperidone—ADRA1A—liver—stomach cancer	0.0005	0.00641	CbGeAlD
Iloperidone—CYP2E1—digestive system—stomach cancer	0.0005	0.0064	CbGeAlD
Iloperidone—ADRA2C—liver—stomach cancer	0.000477	0.00611	CbGeAlD
Iloperidone—SIGMAR1—lymph node—stomach cancer	0.000466	0.00597	CbGeAlD
Iloperidone—CYP1A2—endocrine gland—stomach cancer	0.000459	0.00588	CbGeAlD
Iloperidone—CYP3A5—endocrine gland—stomach cancer	0.000443	0.00567	CbGeAlD
Iloperidone—HTR2A—digestive system—stomach cancer	0.000434	0.00557	CbGeAlD
Iloperidone—HRH1—endocrine gland—stomach cancer	0.00043	0.00551	CbGeAlD
Iloperidone—ADRA2A—endocrine gland—stomach cancer	0.000422	0.00541	CbGeAlD
Iloperidone—CYP1A2—liver—stomach cancer	0.000414	0.0053	CbGeAlD
Iloperidone—CYP2E1—endocrine gland—stomach cancer	0.000413	0.00529	CbGeAlD
Iloperidone—CYP3A4—digestive system—stomach cancer	0.000402	0.00515	CbGeAlD
Iloperidone—CYP3A5—liver—stomach cancer	0.000399	0.00512	CbGeAlD
Iloperidone—CYP2D6—digestive system—stomach cancer	0.000396	0.00507	CbGeAlD
Iloperidone—CYP2E1—liver—stomach cancer	0.000372	0.00477	CbGeAlD
Iloperidone—ADRA2C—lymph node—stomach cancer	0.000366	0.00469	CbGeAlD
Iloperidone—HTR2A—endocrine gland—stomach cancer	0.000359	0.0046	CbGeAlD
Iloperidone—CYP3A4—endocrine gland—stomach cancer	0.000332	0.00426	CbGeAlD
Iloperidone—CYP2D6—endocrine gland—stomach cancer	0.000327	0.00419	CbGeAlD
Iloperidone—HTR2A—liver—stomach cancer	0.000324	0.00415	CbGeAlD
Iloperidone—CYP3A4—liver—stomach cancer	0.000299	0.00384	CbGeAlD
Iloperidone—HRH1—lymph node—stomach cancer	0.000297	0.00381	CbGeAlD
Iloperidone—CYP2D6—liver—stomach cancer	0.000295	0.00378	CbGeAlD
Iloperidone—ADRA2A—lymph node—stomach cancer	0.000292	0.00374	CbGeAlD
Iloperidone—Gefitinib—ALB—stomach cancer	0.000276	0.0424	CrCbGaD
Iloperidone—Somnolence—Irinotecan—stomach cancer	0.000272	0.00166	CcSEcCtD
Iloperidone—Angiopathy—Docetaxel—stomach cancer	0.00027	0.00165	CcSEcCtD
Iloperidone—Dehydration—Epirubicin—stomach cancer	0.00027	0.00165	CcSEcCtD
Iloperidone—Eye disorder—Capecitabine—stomach cancer	0.00027	0.00165	CcSEcCtD
Iloperidone—Tinnitus—Capecitabine—stomach cancer	0.000269	0.00164	CcSEcCtD
Iloperidone—Mediastinal disorder—Docetaxel—stomach cancer	0.000269	0.00164	CcSEcCtD
Iloperidone—Asthma—Methotrexate—stomach cancer	0.000268	0.00164	CcSEcCtD
Iloperidone—Cardiac disorder—Capecitabine—stomach cancer	0.000268	0.00163	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000267	0.00163	CcSEcCtD
Iloperidone—Arrhythmia—Docetaxel—stomach cancer	0.000266	0.00162	CcSEcCtD
Iloperidone—Orthostatic hypotension—Epirubicin—stomach cancer	0.000265	0.00162	CcSEcCtD
Iloperidone—Affect lability—Doxorubicin—stomach cancer	0.000265	0.00161	CcSEcCtD
Iloperidone—Hypokalaemia—Epirubicin—stomach cancer	0.000265	0.00161	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000265	0.00161	CcSEcCtD
Iloperidone—Fatigue—Irinotecan—stomach cancer	0.000264	0.00161	CcSEcCtD
Iloperidone—Paraesthesia—Fluorouracil—stomach cancer	0.000263	0.00161	CcSEcCtD
Iloperidone—Breast disorder—Epirubicin—stomach cancer	0.000263	0.0016	CcSEcCtD
Iloperidone—Angiopathy—Capecitabine—stomach cancer	0.000262	0.0016	CcSEcCtD
Iloperidone—Dyspnoea—Fluorouracil—stomach cancer	0.000262	0.0016	CcSEcCtD
Iloperidone—Mental disorder—Docetaxel—stomach cancer	0.000261	0.00159	CcSEcCtD
Iloperidone—Somnolence—Fluorouracil—stomach cancer	0.000261	0.00159	CcSEcCtD
Iloperidone—Mediastinal disorder—Capecitabine—stomach cancer	0.00026	0.00159	CcSEcCtD
Iloperidone—Nasopharyngitis—Epirubicin—stomach cancer	0.00026	0.00159	CcSEcCtD
Iloperidone—Malnutrition—Docetaxel—stomach cancer	0.00026	0.00158	CcSEcCtD
Iloperidone—Arrhythmia—Capecitabine—stomach cancer	0.000258	0.00157	CcSEcCtD
Iloperidone—Abdominal discomfort—Methotrexate—stomach cancer	0.000257	0.00157	CcSEcCtD
Iloperidone—Gastritis—Epirubicin—stomach cancer	0.000257	0.00157	CcSEcCtD
Iloperidone—Mood swings—Doxorubicin—stomach cancer	0.000255	0.00155	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000253	0.00155	CcSEcCtD
Iloperidone—Mental disorder—Capecitabine—stomach cancer	0.000253	0.00154	CcSEcCtD
Iloperidone—Feeling abnormal—Irinotecan—stomach cancer	0.000252	0.00154	CcSEcCtD
Iloperidone—Malnutrition—Capecitabine—stomach cancer	0.000251	0.00153	CcSEcCtD
Iloperidone—Asthma—Epirubicin—stomach cancer	0.000251	0.00153	CcSEcCtD
Iloperidone—Dysuria—Methotrexate—stomach cancer	0.000251	0.00153	CcSEcCtD
Iloperidone—Dehydration—Doxorubicin—stomach cancer	0.00025	0.00153	CcSEcCtD
Iloperidone—Muscle spasms—Docetaxel—stomach cancer	0.000249	0.00152	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000249	0.00152	CcSEcCtD
Iloperidone—Erectile dysfunction—Methotrexate—stomach cancer	0.000247	0.00151	CcSEcCtD
Iloperidone—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000246	0.0015	CcSEcCtD
Iloperidone—Hypokalaemia—Doxorubicin—stomach cancer	0.000245	0.00149	CcSEcCtD
Iloperidone—Breast disorder—Doxorubicin—stomach cancer	0.000243	0.00148	CcSEcCtD
Iloperidone—Body temperature increased—Irinotecan—stomach cancer	0.000242	0.00148	CcSEcCtD
Iloperidone—Feeling abnormal—Fluorouracil—stomach cancer	0.000242	0.00147	CcSEcCtD
Iloperidone—Muscle spasms—Capecitabine—stomach cancer	0.000242	0.00147	CcSEcCtD
Iloperidone—Nasopharyngitis—Doxorubicin—stomach cancer	0.00024	0.00147	CcSEcCtD
Iloperidone—Anaemia—Docetaxel—stomach cancer	0.00024	0.00146	CcSEcCtD
Iloperidone—Gastritis—Doxorubicin—stomach cancer	0.000238	0.00145	CcSEcCtD
Iloperidone—Vision blurred—Capecitabine—stomach cancer	0.000237	0.00144	CcSEcCtD
Iloperidone—Tremor—Capecitabine—stomach cancer	0.000235	0.00144	CcSEcCtD
Iloperidone—Dysuria—Epirubicin—stomach cancer	0.000235	0.00143	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000233	0.00142	CcSEcCtD
Iloperidone—Stomatitis—Methotrexate—stomach cancer	0.000233	0.00142	CcSEcCtD
Iloperidone—Conjunctivitis—Methotrexate—stomach cancer	0.000233	0.00142	CcSEcCtD
Iloperidone—Asthma—Doxorubicin—stomach cancer	0.000232	0.00142	CcSEcCtD
Iloperidone—Leukopenia—Docetaxel—stomach cancer	0.000232	0.00142	CcSEcCtD
Iloperidone—Anaemia—Capecitabine—stomach cancer	0.000232	0.00142	CcSEcCtD
Iloperidone—Pollakiuria—Epirubicin—stomach cancer	0.000232	0.00142	CcSEcCtD
Iloperidone—Body temperature increased—Fluorouracil—stomach cancer	0.000232	0.00141	CcSEcCtD
Iloperidone—Palpitations—Docetaxel—stomach cancer	0.000229	0.0014	CcSEcCtD
Iloperidone—Weight increased—Epirubicin—stomach cancer	0.000229	0.00139	CcSEcCtD
Iloperidone—Weight decreased—Epirubicin—stomach cancer	0.000227	0.00139	CcSEcCtD
Iloperidone—Hepatobiliary disease—Methotrexate—stomach cancer	0.000226	0.00138	CcSEcCtD
Iloperidone—Epistaxis—Methotrexate—stomach cancer	0.000226	0.00138	CcSEcCtD
Iloperidone—Vertigo—Capecitabine—stomach cancer	0.000226	0.00138	CcSEcCtD
Iloperidone—Leukopenia—Capecitabine—stomach cancer	0.000225	0.00137	CcSEcCtD
Iloperidone—Palpitations—Capecitabine—stomach cancer	0.000222	0.00135	CcSEcCtD
Iloperidone—Arthralgia—Docetaxel—stomach cancer	0.000221	0.00135	CcSEcCtD
Iloperidone—Myalgia—Docetaxel—stomach cancer	0.000221	0.00135	CcSEcCtD
Iloperidone—Asthenia—Irinotecan—stomach cancer	0.00022	0.00134	CcSEcCtD
Iloperidone—Stomatitis—Epirubicin—stomach cancer	0.000218	0.00133	CcSEcCtD
Iloperidone—Conjunctivitis—Epirubicin—stomach cancer	0.000218	0.00133	CcSEcCtD
Iloperidone—Dysuria—Doxorubicin—stomach cancer	0.000217	0.00133	CcSEcCtD
Iloperidone—Dry mouth—Docetaxel—stomach cancer	0.000216	0.00132	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000216	0.00132	CcSEcCtD
Iloperidone—Pollakiuria—Doxorubicin—stomach cancer	0.000215	0.00131	CcSEcCtD
Iloperidone—Myalgia—Capecitabine—stomach cancer	0.000214	0.0013	CcSEcCtD
Iloperidone—Arthralgia—Capecitabine—stomach cancer	0.000214	0.0013	CcSEcCtD
Iloperidone—Confusional state—Docetaxel—stomach cancer	0.000214	0.0013	CcSEcCtD
Iloperidone—Urinary tract disorder—Methotrexate—stomach cancer	0.000212	0.00129	CcSEcCtD
Iloperidone—Hepatobiliary disease—Epirubicin—stomach cancer	0.000212	0.00129	CcSEcCtD
Iloperidone—Oedema—Docetaxel—stomach cancer	0.000212	0.00129	CcSEcCtD
Iloperidone—Weight increased—Doxorubicin—stomach cancer	0.000212	0.00129	CcSEcCtD
Iloperidone—Epistaxis—Epirubicin—stomach cancer	0.000211	0.00129	CcSEcCtD
Iloperidone—Urethral disorder—Methotrexate—stomach cancer	0.000211	0.00128	CcSEcCtD
Iloperidone—Infection—Docetaxel—stomach cancer	0.00021	0.00128	CcSEcCtD
Iloperidone—Weight decreased—Doxorubicin—stomach cancer	0.00021	0.00128	CcSEcCtD
Iloperidone—Diarrhoea—Irinotecan—stomach cancer	0.00021	0.00128	CcSEcCtD
Iloperidone—Dry mouth—Capecitabine—stomach cancer	0.000209	0.00128	CcSEcCtD
Iloperidone—Nervous system disorder—Docetaxel—stomach cancer	0.000208	0.00127	CcSEcCtD
Iloperidone—Confusional state—Capecitabine—stomach cancer	0.000207	0.00126	CcSEcCtD
Iloperidone—Tachycardia—Docetaxel—stomach cancer	0.000207	0.00126	CcSEcCtD
Iloperidone—Oedema—Capecitabine—stomach cancer	0.000205	0.00125	CcSEcCtD
Iloperidone—Infection—Capecitabine—stomach cancer	0.000204	0.00124	CcSEcCtD
Iloperidone—Dizziness—Irinotecan—stomach cancer	0.000203	0.00124	CcSEcCtD
Iloperidone—Stomatitis—Doxorubicin—stomach cancer	0.000202	0.00123	CcSEcCtD
Iloperidone—Conjunctivitis—Doxorubicin—stomach cancer	0.000201	0.00123	CcSEcCtD
Iloperidone—Nervous system disorder—Capecitabine—stomach cancer	0.000201	0.00123	CcSEcCtD
Iloperidone—Eye disorder—Methotrexate—stomach cancer	0.000201	0.00122	CcSEcCtD
Iloperidone—Diarrhoea—Fluorouracil—stomach cancer	0.000201	0.00122	CcSEcCtD
Iloperidone—Tinnitus—Methotrexate—stomach cancer	0.0002	0.00122	CcSEcCtD
Iloperidone—Tachycardia—Capecitabine—stomach cancer	0.0002	0.00122	CcSEcCtD
Iloperidone—Cardiac disorder—Methotrexate—stomach cancer	0.000199	0.00122	CcSEcCtD
Iloperidone—Urinary tract disorder—Epirubicin—stomach cancer	0.000199	0.00121	CcSEcCtD
Iloperidone—Hypotension—Docetaxel—stomach cancer	0.000198	0.00121	CcSEcCtD
Iloperidone—Connective tissue disorder—Epirubicin—stomach cancer	0.000198	0.00121	CcSEcCtD
Iloperidone—Urethral disorder—Epirubicin—stomach cancer	0.000197	0.0012	CcSEcCtD
Iloperidone—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000196	0.0012	CcSEcCtD
Iloperidone—Epistaxis—Doxorubicin—stomach cancer	0.000195	0.00119	CcSEcCtD
Iloperidone—Angiopathy—Methotrexate—stomach cancer	0.000195	0.00119	CcSEcCtD
Iloperidone—Dizziness—Fluorouracil—stomach cancer	0.000194	0.00118	CcSEcCtD
Iloperidone—Mediastinal disorder—Methotrexate—stomach cancer	0.000194	0.00118	CcSEcCtD
Iloperidone—Rash—Irinotecan—stomach cancer	0.000193	0.00118	CcSEcCtD
Iloperidone—Dermatitis—Irinotecan—stomach cancer	0.000193	0.00118	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000193	0.00118	CcSEcCtD
Iloperidone—Hypotension—Capecitabine—stomach cancer	0.000192	0.00117	CcSEcCtD
Iloperidone—Paraesthesia—Docetaxel—stomach cancer	0.00019	0.00116	CcSEcCtD
Iloperidone—Dyspnoea—Docetaxel—stomach cancer	0.000189	0.00115	CcSEcCtD
Iloperidone—Somnolence—Docetaxel—stomach cancer	0.000188	0.00115	CcSEcCtD
Iloperidone—Mental disorder—Methotrexate—stomach cancer	0.000188	0.00115	CcSEcCtD
Iloperidone—Eye disorder—Epirubicin—stomach cancer	0.000188	0.00115	CcSEcCtD
Iloperidone—Tinnitus—Epirubicin—stomach cancer	0.000187	0.00114	CcSEcCtD
Iloperidone—Malnutrition—Methotrexate—stomach cancer	0.000187	0.00114	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000187	0.00114	CcSEcCtD
Iloperidone—Cardiac disorder—Epirubicin—stomach cancer	0.000187	0.00114	CcSEcCtD
Iloperidone—Rash—Fluorouracil—stomach cancer	0.000185	0.00113	CcSEcCtD
Iloperidone—Dermatitis—Fluorouracil—stomach cancer	0.000185	0.00113	CcSEcCtD
Iloperidone—Paraesthesia—Capecitabine—stomach cancer	0.000184	0.00112	CcSEcCtD
Iloperidone—Urinary tract disorder—Doxorubicin—stomach cancer	0.000184	0.00112	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000183	0.00112	CcSEcCtD
Iloperidone—Connective tissue disorder—Doxorubicin—stomach cancer	0.000183	0.00112	CcSEcCtD
Iloperidone—Dyspnoea—Capecitabine—stomach cancer	0.000183	0.00111	CcSEcCtD
Iloperidone—Fatigue—Docetaxel—stomach cancer	0.000183	0.00111	CcSEcCtD
Iloperidone—Angiopathy—Epirubicin—stomach cancer	0.000182	0.00111	CcSEcCtD
Iloperidone—Urethral disorder—Doxorubicin—stomach cancer	0.000182	0.00111	CcSEcCtD
Iloperidone—Nausea—Irinotecan—stomach cancer	0.000182	0.00111	CcSEcCtD
Iloperidone—Mediastinal disorder—Epirubicin—stomach cancer	0.000181	0.00111	CcSEcCtD
Iloperidone—Arrhythmia—Epirubicin—stomach cancer	0.00018	0.0011	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000177	0.00108	CcSEcCtD
Iloperidone—Fatigue—Capecitabine—stomach cancer	0.000177	0.00108	CcSEcCtD
Iloperidone—Vision blurred—Methotrexate—stomach cancer	0.000176	0.00108	CcSEcCtD
Iloperidone—Mental disorder—Epirubicin—stomach cancer	0.000176	0.00107	CcSEcCtD
Iloperidone—Malnutrition—Epirubicin—stomach cancer	0.000175	0.00107	CcSEcCtD
Iloperidone—Feeling abnormal—Docetaxel—stomach cancer	0.000175	0.00106	CcSEcCtD
Iloperidone—Nausea—Fluorouracil—stomach cancer	0.000174	0.00106	CcSEcCtD
Iloperidone—Eye disorder—Doxorubicin—stomach cancer	0.000174	0.00106	CcSEcCtD
Iloperidone—Tinnitus—Doxorubicin—stomach cancer	0.000173	0.00106	CcSEcCtD
Iloperidone—Anaemia—Methotrexate—stomach cancer	0.000173	0.00105	CcSEcCtD
Iloperidone—Cardiac disorder—Doxorubicin—stomach cancer	0.000173	0.00105	CcSEcCtD
Iloperidone—Feeling abnormal—Capecitabine—stomach cancer	0.000169	0.00103	CcSEcCtD
Iloperidone—Angiopathy—Doxorubicin—stomach cancer	0.000169	0.00103	CcSEcCtD
Iloperidone—Muscle spasms—Epirubicin—stomach cancer	0.000168	0.00103	CcSEcCtD
Iloperidone—Vertigo—Methotrexate—stomach cancer	0.000168	0.00102	CcSEcCtD
Iloperidone—Mediastinal disorder—Doxorubicin—stomach cancer	0.000168	0.00102	CcSEcCtD
Iloperidone—Body temperature increased—Docetaxel—stomach cancer	0.000167	0.00102	CcSEcCtD
Iloperidone—Leukopenia—Methotrexate—stomach cancer	0.000167	0.00102	CcSEcCtD
Iloperidone—Arrhythmia—Doxorubicin—stomach cancer	0.000166	0.00101	CcSEcCtD
Iloperidone—Vision blurred—Epirubicin—stomach cancer	0.000165	0.00101	CcSEcCtD
Iloperidone—Mental disorder—Doxorubicin—stomach cancer	0.000163	0.000994	CcSEcCtD
Iloperidone—Body temperature increased—Capecitabine—stomach cancer	0.000162	0.000989	CcSEcCtD
Iloperidone—Malnutrition—Doxorubicin—stomach cancer	0.000162	0.000988	CcSEcCtD
Iloperidone—Anaemia—Epirubicin—stomach cancer	0.000162	0.000987	CcSEcCtD
Iloperidone—Agitation—Epirubicin—stomach cancer	0.000161	0.000981	CcSEcCtD
Iloperidone—Arthralgia—Methotrexate—stomach cancer	0.000159	0.000971	CcSEcCtD
Iloperidone—Myalgia—Methotrexate—stomach cancer	0.000159	0.000971	CcSEcCtD
Iloperidone—Vertigo—Epirubicin—stomach cancer	0.000157	0.000959	CcSEcCtD
Iloperidone—Leukopenia—Epirubicin—stomach cancer	0.000157	0.000956	CcSEcCtD
Iloperidone—Muscle spasms—Doxorubicin—stomach cancer	0.000156	0.00095	CcSEcCtD
Iloperidone—Palpitations—Epirubicin—stomach cancer	0.000155	0.000943	CcSEcCtD
Iloperidone—Confusional state—Methotrexate—stomach cancer	0.000154	0.000939	CcSEcCtD
Iloperidone—Vision blurred—Doxorubicin—stomach cancer	0.000153	0.000931	CcSEcCtD
Iloperidone—Asthenia—Docetaxel—stomach cancer	0.000152	0.000927	CcSEcCtD
Iloperidone—Infection—Methotrexate—stomach cancer	0.000152	0.000925	CcSEcCtD
Iloperidone—Nervous system disorder—Methotrexate—stomach cancer	0.00015	0.000913	CcSEcCtD
Iloperidone—Anaemia—Doxorubicin—stomach cancer	0.00015	0.000913	CcSEcCtD
Iloperidone—Arthralgia—Epirubicin—stomach cancer	0.000149	0.000909	CcSEcCtD
Iloperidone—Myalgia—Epirubicin—stomach cancer	0.000149	0.000909	CcSEcCtD
Iloperidone—Agitation—Doxorubicin—stomach cancer	0.000149	0.000908	CcSEcCtD
Iloperidone—Asthenia—Capecitabine—stomach cancer	0.000147	0.000897	CcSEcCtD
Iloperidone—Dry mouth—Epirubicin—stomach cancer	0.000146	0.000889	CcSEcCtD
Iloperidone—Vertigo—Doxorubicin—stomach cancer	0.000146	0.000887	CcSEcCtD
Iloperidone—Leukopenia—Doxorubicin—stomach cancer	0.000145	0.000884	CcSEcCtD
Iloperidone—Diarrhoea—Docetaxel—stomach cancer	0.000145	0.000884	CcSEcCtD
Iloperidone—Confusional state—Epirubicin—stomach cancer	0.000144	0.000878	CcSEcCtD
Iloperidone—Palpitations—Doxorubicin—stomach cancer	0.000143	0.000873	CcSEcCtD
Iloperidone—Oedema—Epirubicin—stomach cancer	0.000143	0.000871	CcSEcCtD
Iloperidone—Hypotension—Methotrexate—stomach cancer	0.000143	0.00087	CcSEcCtD
Iloperidone—Infection—Epirubicin—stomach cancer	0.000142	0.000866	CcSEcCtD
Iloperidone—Diarrhoea—Capecitabine—stomach cancer	0.00014	0.000856	CcSEcCtD
Iloperidone—Nervous system disorder—Epirubicin—stomach cancer	0.00014	0.000854	CcSEcCtD
Iloperidone—Dizziness—Docetaxel—stomach cancer	0.00014	0.000854	CcSEcCtD
Iloperidone—Tachycardia—Epirubicin—stomach cancer	0.000139	0.00085	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000139	0.000848	CcSEcCtD
Iloperidone—Arthralgia—Doxorubicin—stomach cancer	0.000138	0.000841	CcSEcCtD
Iloperidone—Myalgia—Doxorubicin—stomach cancer	0.000138	0.000841	CcSEcCtD
Iloperidone—Paraesthesia—Methotrexate—stomach cancer	0.000137	0.000836	CcSEcCtD
Iloperidone—Dyspnoea—Methotrexate—stomach cancer	0.000136	0.00083	CcSEcCtD
Iloperidone—Somnolence—Methotrexate—stomach cancer	0.000136	0.000828	CcSEcCtD
Iloperidone—Dizziness—Capecitabine—stomach cancer	0.000136	0.000827	CcSEcCtD
Iloperidone—Dry mouth—Doxorubicin—stomach cancer	0.000135	0.000822	CcSEcCtD
Iloperidone—Rash—Docetaxel—stomach cancer	0.000134	0.000814	CcSEcCtD
Iloperidone—Hypotension—Epirubicin—stomach cancer	0.000133	0.000814	CcSEcCtD
Iloperidone—Dermatitis—Docetaxel—stomach cancer	0.000133	0.000814	CcSEcCtD
Iloperidone—Confusional state—Doxorubicin—stomach cancer	0.000133	0.000813	CcSEcCtD
Iloperidone—Oedema—Doxorubicin—stomach cancer	0.000132	0.000806	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000132	0.000804	CcSEcCtD
Iloperidone—Fatigue—Methotrexate—stomach cancer	0.000132	0.000803	CcSEcCtD
Iloperidone—Infection—Doxorubicin—stomach cancer	0.000131	0.000801	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00013	0.000794	CcSEcCtD
Iloperidone—Nervous system disorder—Doxorubicin—stomach cancer	0.00013	0.000791	CcSEcCtD
Iloperidone—Rash—Capecitabine—stomach cancer	0.000129	0.000789	CcSEcCtD
Iloperidone—Dermatitis—Capecitabine—stomach cancer	0.000129	0.000788	CcSEcCtD
Iloperidone—Tachycardia—Doxorubicin—stomach cancer	0.000129	0.000787	CcSEcCtD
Iloperidone—Paraesthesia—Epirubicin—stomach cancer	0.000128	0.000782	CcSEcCtD
Iloperidone—Dyspnoea—Epirubicin—stomach cancer	0.000127	0.000777	CcSEcCtD
Iloperidone—Somnolence—Epirubicin—stomach cancer	0.000127	0.000775	CcSEcCtD
Iloperidone—Nausea—Docetaxel—stomach cancer	0.000126	0.000767	CcSEcCtD
Iloperidone—Feeling abnormal—Methotrexate—stomach cancer	0.000126	0.000767	CcSEcCtD
Iloperidone—Hypotension—Doxorubicin—stomach cancer	0.000124	0.000753	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000123	0.000752	CcSEcCtD
Iloperidone—Fatigue—Epirubicin—stomach cancer	0.000123	0.000751	CcSEcCtD
Iloperidone—Nausea—Capecitabine—stomach cancer	0.000122	0.000743	CcSEcCtD
Iloperidone—Body temperature increased—Methotrexate—stomach cancer	0.000121	0.000736	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00012	0.000734	CcSEcCtD
Iloperidone—Paraesthesia—Doxorubicin—stomach cancer	0.000119	0.000724	CcSEcCtD
Iloperidone—Dyspnoea—Doxorubicin—stomach cancer	0.000118	0.000719	CcSEcCtD
Iloperidone—Feeling abnormal—Epirubicin—stomach cancer	0.000118	0.000718	CcSEcCtD
Iloperidone—Somnolence—Doxorubicin—stomach cancer	0.000118	0.000717	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000114	0.000696	CcSEcCtD
Iloperidone—Fatigue—Doxorubicin—stomach cancer	0.000114	0.000695	CcSEcCtD
Iloperidone—Body temperature increased—Epirubicin—stomach cancer	0.000113	0.000689	CcSEcCtD
Iloperidone—Asthenia—Methotrexate—stomach cancer	0.00011	0.000668	CcSEcCtD
Iloperidone—Feeling abnormal—Doxorubicin—stomach cancer	0.000109	0.000664	CcSEcCtD
Iloperidone—Body temperature increased—Doxorubicin—stomach cancer	0.000104	0.000637	CcSEcCtD
Iloperidone—Diarrhoea—Methotrexate—stomach cancer	0.000104	0.000637	CcSEcCtD
Iloperidone—Asthenia—Epirubicin—stomach cancer	0.000102	0.000625	CcSEcCtD
Iloperidone—Dizziness—Methotrexate—stomach cancer	0.000101	0.000616	CcSEcCtD
Iloperidone—Diarrhoea—Epirubicin—stomach cancer	9.77e-05	0.000596	CcSEcCtD
Iloperidone—Rash—Methotrexate—stomach cancer	9.62e-05	0.000587	CcSEcCtD
Iloperidone—Dermatitis—Methotrexate—stomach cancer	9.62e-05	0.000586	CcSEcCtD
Iloperidone—Asthenia—Doxorubicin—stomach cancer	9.48e-05	0.000578	CcSEcCtD
Iloperidone—Dizziness—Epirubicin—stomach cancer	9.45e-05	0.000576	CcSEcCtD
Iloperidone—Nausea—Methotrexate—stomach cancer	9.07e-05	0.000553	CcSEcCtD
Iloperidone—Diarrhoea—Doxorubicin—stomach cancer	9.04e-05	0.000552	CcSEcCtD
Iloperidone—Rash—Epirubicin—stomach cancer	9.01e-05	0.000549	CcSEcCtD
Iloperidone—Dermatitis—Epirubicin—stomach cancer	9e-05	0.000549	CcSEcCtD
Iloperidone—Dizziness—Doxorubicin—stomach cancer	8.74e-05	0.000533	CcSEcCtD
Iloperidone—Nausea—Epirubicin—stomach cancer	8.49e-05	0.000518	CcSEcCtD
Iloperidone—Rash—Doxorubicin—stomach cancer	8.33e-05	0.000508	CcSEcCtD
Iloperidone—Dermatitis—Doxorubicin—stomach cancer	8.33e-05	0.000508	CcSEcCtD
Iloperidone—Nausea—Doxorubicin—stomach cancer	7.85e-05	0.000479	CcSEcCtD
Iloperidone—HTR1A—Signaling by GPCR—IL6—stomach cancer	4.58e-06	3.18e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GSTM1—stomach cancer	4.57e-06	3.17e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—stomach cancer	4.55e-06	3.16e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	4.55e-06	3.16e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—stomach cancer	4.54e-06	3.16e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MAPK1—stomach cancer	4.54e-06	3.16e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EGFR—stomach cancer	4.54e-06	3.16e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	4.54e-06	3.15e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—STAT3—stomach cancer	4.5e-06	3.13e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—KRAS—stomach cancer	4.49e-06	3.12e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—stomach cancer	4.48e-06	3.12e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—KRAS—stomach cancer	4.48e-06	3.12e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCND1—stomach cancer	4.48e-06	3.12e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—JUN—stomach cancer	4.47e-06	3.11e-05	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	4.47e-06	3.11e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	4.47e-06	3.1e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	4.46e-06	3.1e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCND1—stomach cancer	4.46e-06	3.1e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ERBB2—stomach cancer	4.45e-06	3.1e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	4.45e-06	3.1e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—KRAS—stomach cancer	4.45e-06	3.1e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—JUN—stomach cancer	4.45e-06	3.09e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—STAT3—stomach cancer	4.44e-06	3.09e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—stomach cancer	4.43e-06	3.08e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	4.42e-06	3.07e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CAV1—stomach cancer	4.39e-06	3.06e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOA1—stomach cancer	4.38e-06	3.05e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ERBB2—stomach cancer	4.38e-06	3.05e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ERBB2—stomach cancer	4.37e-06	3.04e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	4.37e-06	3.04e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MMP9—stomach cancer	4.35e-06	3.03e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCND1—stomach cancer	4.34e-06	3.02e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	4.34e-06	3.02e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MMP9—stomach cancer	4.33e-06	3.01e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—JUN—stomach cancer	4.33e-06	3.01e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	4.31e-06	3e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RHOA—stomach cancer	4.31e-06	3e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MAPK3—stomach cancer	4.3e-06	2.99e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ERCC2—stomach cancer	4.29e-06	2.98e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	4.29e-06	2.98e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—KRAS—stomach cancer	4.29e-06	2.98e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—stomach cancer	4.28e-06	2.98e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—stomach cancer	4.27e-06	2.97e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOS3—stomach cancer	4.26e-06	2.96e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MAPK3—stomach cancer	4.24e-06	2.95e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MAPK8—stomach cancer	4.23e-06	2.94e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL8—stomach cancer	4.22e-06	2.94e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MMP9—stomach cancer	4.21e-06	2.93e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MAPK8—stomach cancer	4.21e-06	2.93e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—HRAS—stomach cancer	4.2e-06	2.92e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	4.2e-06	2.92e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MYC—stomach cancer	4.18e-06	2.91e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL8—stomach cancer	4.16e-06	2.89e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL8—stomach cancer	4.15e-06	2.88e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—HRAS—stomach cancer	4.13e-06	2.87e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MYC—stomach cancer	4.13e-06	2.87e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CDKN1B—stomach cancer	4.13e-06	2.87e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—PIK3CA—stomach cancer	4.12e-06	2.87e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—HRAS—stomach cancer	4.12e-06	2.87e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—PIK3CA—stomach cancer	4.12e-06	2.86e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	4.1e-06	2.85e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	4.09e-06	2.85e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MAPK1—stomach cancer	4.09e-06	2.84e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EGFR—stomach cancer	4.09e-06	2.84e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	4.07e-06	2.83e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	4.06e-06	2.82e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	4.06e-06	2.82e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CDKN1B—stomach cancer	4.05e-06	2.82e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	4.04e-06	2.81e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MAPK1—stomach cancer	4.04e-06	2.81e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—stomach cancer	4.04e-06	2.81e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EGFR—stomach cancer	4.04e-06	2.81e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—stomach cancer	4.02e-06	2.79e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—stomach cancer	3.99e-06	2.77e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	3.99e-06	2.77e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—stomach cancer	3.98e-06	2.77e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	3.97e-06	2.76e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—stomach cancer	3.96e-06	2.75e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—stomach cancer	3.95e-06	2.75e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—stomach cancer	3.94e-06	2.74e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—PIK3CA—stomach cancer	3.94e-06	2.74e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCND1—stomach cancer	3.94e-06	2.74e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—JUN—stomach cancer	3.93e-06	2.73e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.91e-06	2.72e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—stomach cancer	3.91e-06	2.72e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—stomach cancer	3.89e-06	2.7e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCND1—stomach cancer	3.87e-06	2.69e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—stomach cancer	3.87e-06	2.69e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—STAT3—stomach cancer	3.87e-06	2.69e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—JUN—stomach cancer	3.86e-06	2.69e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCND1—stomach cancer	3.86e-06	2.69e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—KRAS—stomach cancer	3.86e-06	2.69e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARG—stomach cancer	3.86e-06	2.69e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—JUN—stomach cancer	3.86e-06	2.68e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—STAT3—stomach cancer	3.85e-06	2.68e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTP1—stomach cancer	3.83e-06	2.67e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MMP9—stomach cancer	3.82e-06	2.66e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—HRAS—stomach cancer	3.81e-06	2.65e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—stomach cancer	3.81e-06	2.65e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—KRAS—stomach cancer	3.81e-06	2.65e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—HRAS—stomach cancer	3.81e-06	2.65e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CDKN1A—stomach cancer	3.81e-06	2.65e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCND1—stomach cancer	3.79e-06	2.64e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—HRAS—stomach cancer	3.79e-06	2.63e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—JUN—stomach cancer	3.78e-06	2.63e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMOX1—stomach cancer	3.78e-06	2.63e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	3.78e-06	2.63e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	3.78e-06	2.63e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MMP9—stomach cancer	3.76e-06	2.61e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	3.76e-06	2.61e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MMP9—stomach cancer	3.75e-06	2.61e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	3.75e-06	2.6e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—STAT3—stomach cancer	3.74e-06	2.6e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CDKN1A—stomach cancer	3.74e-06	2.6e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CAV1—stomach cancer	3.72e-06	2.59e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MAPK8—stomach cancer	3.72e-06	2.58e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOA1—stomach cancer	3.71e-06	2.58e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MAPK3—stomach cancer	3.7e-06	2.57e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	3.69e-06	2.57e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MMP9—stomach cancer	3.68e-06	2.56e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MAPK3—stomach cancer	3.68e-06	2.56e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	3.67e-06	2.55e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MAPK8—stomach cancer	3.66e-06	2.54e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—stomach cancer	3.65e-06	2.54e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MAPK8—stomach cancer	3.65e-06	2.54e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—HRAS—stomach cancer	3.65e-06	2.54e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—stomach cancer	3.65e-06	2.54e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PIK3CA—stomach cancer	3.64e-06	2.53e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—stomach cancer	3.62e-06	2.52e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—stomach cancer	3.6e-06	2.5e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MYC—stomach cancer	3.6e-06	2.5e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	3.58e-06	2.49e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	3.58e-06	2.49e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MYC—stomach cancer	3.58e-06	2.49e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TYMS—stomach cancer	3.57e-06	2.48e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.56e-06	2.47e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PIK3CA—stomach cancer	3.55e-06	2.47e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PIK3CA—stomach cancer	3.53e-06	2.46e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTM1—stomach cancer	3.52e-06	2.45e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCND1—stomach cancer	3.52e-06	2.45e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MAPK1—stomach cancer	3.52e-06	2.45e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EGFR—stomach cancer	3.52e-06	2.45e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—JUN—stomach cancer	3.52e-06	2.44e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PIK3CA—stomach cancer	3.5e-06	2.44e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MAPK1—stomach cancer	3.5e-06	2.43e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EGFR—stomach cancer	3.5e-06	2.43e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—stomach cancer	3.49e-06	2.43e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MYC—stomach cancer	3.48e-06	2.42e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—stomach cancer	3.47e-06	2.41e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—stomach cancer	3.43e-06	2.39e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—stomach cancer	3.43e-06	2.39e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MMP9—stomach cancer	3.42e-06	2.38e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	3.41e-06	2.37e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	3.4e-06	2.37e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EGFR—stomach cancer	3.4e-06	2.37e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—STAT3—stomach cancer	3.4e-06	2.36e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—stomach cancer	3.39e-06	2.36e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—stomach cancer	3.38e-06	2.35e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—stomach cancer	3.37e-06	2.34e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—STAT3—stomach cancer	3.34e-06	2.32e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—STAT3—stomach cancer	3.34e-06	2.32e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	3.33e-06	2.31e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—NOS3—stomach cancer	3.32e-06	2.31e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—KRAS—stomach cancer	3.32e-06	2.31e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ERCC2—stomach cancer	3.31e-06	2.3e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	3.31e-06	2.3e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—KRAS—stomach cancer	3.31e-06	2.3e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—HRAS—stomach cancer	3.28e-06	2.28e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—STAT3—stomach cancer	3.27e-06	2.28e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARG—stomach cancer	3.27e-06	2.28e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MAPK3—stomach cancer	3.25e-06	2.26e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—HRAS—stomach cancer	3.24e-06	2.25e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—KRAS—stomach cancer	3.21e-06	2.24e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MAPK3—stomach cancer	3.19e-06	2.22e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MAPK3—stomach cancer	3.19e-06	2.22e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MYC—stomach cancer	3.16e-06	2.19e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—stomach cancer	3.14e-06	2.19e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	3.13e-06	2.17e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—stomach cancer	3.11e-06	2.17e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MYC—stomach cancer	3.11e-06	2.16e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—stomach cancer	3.1e-06	2.16e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MYC—stomach cancer	3.1e-06	2.16e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MAPK1—stomach cancer	3.09e-06	2.15e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EGFR—stomach cancer	3.09e-06	2.15e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	3.07e-06	2.14e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	3.05e-06	2.12e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MYC—stomach cancer	3.04e-06	2.11e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—STAT3—stomach cancer	3.04e-06	2.11e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MAPK1—stomach cancer	3.04e-06	2.11e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—stomach cancer	3.04e-06	2.11e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EGFR—stomach cancer	3.04e-06	2.11e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	3.04e-06	2.11e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MAPK1—stomach cancer	3.03e-06	2.11e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EGFR—stomach cancer	3.03e-06	2.11e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.98e-06	2.07e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.97e-06	2.07e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	2.95e-06	2.05e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—stomach cancer	2.95e-06	2.05e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—stomach cancer	2.94e-06	2.05e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—stomach cancer	2.94e-06	2.04e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—KRAS—stomach cancer	2.92e-06	2.03e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.91e-06	2.02e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CAV1—stomach cancer	2.87e-06	2e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.87e-06	2e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.87e-06	1.99e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOA1—stomach cancer	2.87e-06	1.99e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—KRAS—stomach cancer	2.86e-06	1.99e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—stomach cancer	2.86e-06	1.99e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.83e-06	1.96e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.82e-06	1.96e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—NOS3—stomach cancer	2.81e-06	1.96e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.81e-06	1.95e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HRAS—stomach cancer	2.81e-06	1.95e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	2.76e-06	1.92e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EGFR—stomach cancer	2.76e-06	1.92e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HRAS—stomach cancer	2.73e-06	1.9e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—stomach cancer	2.7e-06	1.88e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—stomach cancer	2.69e-06	1.87e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.68e-06	1.86e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.64e-06	1.83e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PIK3CA—stomach cancer	2.63e-06	1.83e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PIK3CA—stomach cancer	2.63e-06	1.83e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.63e-06	1.83e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—stomach cancer	2.62e-06	1.82e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—KRAS—stomach cancer	2.61e-06	1.82e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—stomach cancer	2.59e-06	1.8e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.58e-06	1.8e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—stomach cancer	2.57e-06	1.79e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—stomach cancer	2.55e-06	1.77e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—stomach cancer	2.55e-06	1.77e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARG—stomach cancer	2.53e-06	1.76e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.5e-06	1.74e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HRAS—stomach cancer	2.48e-06	1.72e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—HRAS—stomach cancer	2.44e-06	1.7e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HRAS—stomach cancer	2.43e-06	1.69e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	2.4e-06	1.67e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.39e-06	1.66e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—stomach cancer	2.37e-06	1.65e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—stomach cancer	2.33e-06	1.62e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—stomach cancer	2.33e-06	1.62e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—stomach cancer	2.32e-06	1.61e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.29e-06	1.59e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—stomach cancer	2.27e-06	1.58e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HRAS—stomach cancer	2.22e-06	1.54e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NOS3—stomach cancer	2.17e-06	1.51e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—stomach cancer	2.12e-06	1.48e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—stomach cancer	1.99e-06	1.38e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.87e-06	1.3e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.58e-06	1.1e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.22e-06	8.5e-06	CbGpPWpGaD
